Cellular fatty acid-deficient Pandoraea isolated from a patient with cystic fibrosis

References

1. Coenye T., Falsen E., Hoste B., Ohlen M., Goris J., Govan J. R., Gillis M., Vandamme P. 2000; Description of Pandoraea gen.nov. with Pandoraea apista sp. nov.,Pandoraea pulmonica sp. nov., Pandoraea sputurum sp.nov., and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol 50:887–899 [CrossRef]
   [Google Scholar]
2. Daneshvar M. I., Hollis D., Steigerwalt A. G., Whitney A. M., Spangler L., Douglas M. P., Jordan J. G., MacGregor J. P., Hill B. C. other authors 2001; Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterisation of three new Pandoraea genomospecies. J Clin Microbiol 39:1819–1826 [CrossRef]
   [Google Scholar]
3. Krejči E., Kroppenstedt R. 2006; Differentiation of species combined into Burkholderia cepacia complex and related taxa on the basis of their fatty acid patterns. J Clin Microbiol 44:1159–1164 [CrossRef]
   [Google Scholar]
4. Moore J. E., Reid A., Millar B. C., Jiru X., Mccaughan J., Goldsmith C. E., Collins J., Murphy P. G., Elborn J. S. 2002; Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identification. Br J Biomed Sci 59:164–166
   [Google Scholar]
5. Segonds C., Paute S., Chabanon G. 2003; Use of amplified DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis. J Clin Microbiol 41:3415–3418 [CrossRef]
   [Google Scholar]